← Return to Any experiences with Provenge immunotherapy for prostate cancer?
DiscussionAny experiences with Provenge immunotherapy for prostate cancer?
Prostate Cancer | Last Active: Nov 3, 2025 | Replies (37)Comment receiving replies
Replies to "I just completed paperwork for the treatment of Provenge. Paperwork was sent to my insurance for..."
Had a recent conversation with a client about our PC and he had the Provenge 12 years ago and had a 1900 PSA.
Still on Xtandi, about 70 now and undetectable. Amazing!
Connect

I know a few people who have had Provenge. It’s good to have it when your PSA is still low. It is hoped that will give extra time. Actual results are a little hard to estimate.
In the IMPACT clinical trial, Provenge extended the median overall survival of men with metastatic castration-resistant prostate cancer (mCRPC) by 4.1 months compared to placebo. The median survival in the Provenge group was 25.8 months versus 21.7 months in the control group.